Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The KITE Study: OATD-01 in Active Pulmonary Sarcoidosis
NCT06205121Phase 2Recruiting
- Sponsor
- Molecure
- Start
- Mar 2024
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of OATD-01 in pulmonary sarcoidosis, sponsored by Molecure. Started Mar 2024; status: recruiting.
02
Drugs
OATD-01
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT06205121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205121.